Resveratrol metabolites can promote a moderate cellular senescence induction in breast cancer cells, which involves inhibiting cell growth by G2/M phase arrest through the p53/p21Cip1/WAF1 pathway [180]. This evidence concerns the gene TP53 and breast carcinoma.